Skip to main

Myelodysplastic Syndromes Research

Winship Cancer Institute of Emory University is a leader in myelodysplastic syndromes research. As such, you’ll have access to treatment options that aren’t available anywhere else.

Researching Myelodysplastic Syndromes Developing Novel Therapies at Winship

Cancer survival rates are improving all the time thanks to research being done at leading cancer centers like Winship Cancer Institute of Emory University.

We’re honored to be among a select number of National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in the country developing and collaborating on lifesaving cancer clinical trials, including some involving research of myelodysplastic syndromes.

Types of Myelodysplastic Syndromes Research

Winship researchers are leading the way and changing how the world prevents, detects, diagnoses, treats and survives all forms of cancer, including myelodysplastic syndromes. We pioneer discoveries in the lab that are translated into the latest, most effective treatments in the clinic. Our bench-to-bedside research of myelodysplastic syndromes enables us to discover, develop and deliver transformative procedures, technologies, diagnostics and treatments.

In the area of myelodysplastic syndromes, we’re currently involved in research testing various new therapies, alone or in combination with standard treatments, as well as ongoing efforts to improve stem cell and marrow transplantation outcomes.

Myelodysplastic Syndromes Clinical Trials

At Winship, it’s our responsibility to match patients with the treatment that will provide them the best possible outcome, whether that’s using standard therapy or novel treatments in clinical trial.

Participating in Myelodysplastic Syndromes Clinical Research

Clinical trials are controlled studies that test the newest interventions on a disease. They offer participants early access to treatments that are not yet commercially available. As a research center, our physicians and scientists will make every effort to match you with a clinical trial that targets your unique cancer. It’s best if you enroll from the very beginning, so let your doctor know on your first visit if you’re interested in learning more about a clinical trial. Most clinical trials are supplemental, meaning you’ll still receive the standard therapy in addition to any treatment being studied.

Support for Clinical Trial Participation

Our clinical investigators conduct myelodysplastic syndromes research at the following locations:

Talk with your doctor about whether you are eligible to participate in a clinical trial. We welcome trial participants from all over Georgia and beyond. Our supportive oncology team can assist you with services, such as finding affordable accommodations near Winship for the duration of your clinical trial.

Georgia Blood Cancer Trials Network

Clinical researchers at Winship, along with partners and community-based systems in Atlanta and throughout the state, are leading the Georgia Blood Cancer Trials Network. This network makes innovative, investigational therapies and treatments more accessible to Georgia patients with blood cancer who reside outside of metropolitan Atlanta, including rural areas where higher poverty rates and longer travel distances make clinical trial participation more difficult. At Winship, we conduct clinical trials as part of the network at multiple locations.